Cullinan Therapeutics CGEM
NASDAQ CGEM
$22.15 -0.01 (-0.07%)
As of: Sep 4, 2026 · 2:27 PM EDT

Cullinan Therapeutics (CGEM) Prepaid Assets (2020 - 2026)

Cullinan Therapeutics (CGEM) posted quarterly Prepaid Assets of $9.5 million for Q1 2026, down 31.72% year-over-year from $13.9 million in Q1 2025, and up 7.47% quarter-over-quarter from $8.9 million in Q4 2025.

Analysis

Cullinan Therapeutics (CGEM) Prepaid Assets (2020 - 2026) Analysis & Trends

Cullinan Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $9.5 million for Q1 2026.

  • In Q1 2026, Prepaid Assets fell 31.72% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (down 31.72% YoY), while the FY2025 annual figure was $8.9 million, down 43.53% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $9.5 million, up from $8.9 million in the prior quarter.
  • The five-year high for Prepaid Assets was $15.7 million in Q4 2024, with the low at $619000.0 in Q3 2022.
  • The 5-year median for Prepaid Assets is $9.6 million (2025), against an average of $9.4 million.
  • The sharpest annual moves came in 2023 and 2024: Prepaid Assets tumbled 94.77% in 2023, then jumped 2372.37% in 2024.
  • Cullinan Therapeutics' Prepaid Assets stood at $7.2 million in 2022, then surged by 82.79% to $13.1 million in 2023, then gained by 19.56% to $15.7 million in 2024, then plunged by 43.53% to $8.9 million in 2025, then grew by 7.47% to $9.5 million in 2026.
  • Business Quant data shows CGEM's Prepaid Assets at $9.5 million in Q1 2026, $8.9 million in Q4 2025, and $9.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Cullinan Therapeutics 1.37 Bn 1.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.44 Mn
Mar 31, 2026 9.52 Mn
Dec 31, 2025 8.86 Mn
Sep 30, 2025 9.64 Mn
Jun 30, 2025 10.43 Mn
Mar 31, 2025 13.95 Mn
Dec 31, 2024 15.69 Mn
Sep 30, 2024 13.96 Mn
Jun 30, 2024 15.30 Mn
Mar 31, 2024 12.71 Mn
Dec 31, 2023 13.12 Mn
Sep 30, 2023 10.28 Mn
Jun 30, 2023 6.44 Mn
Mar 31, 2023 8.33 Mn
Dec 31, 2022 7.18 Mn
Sep 30, 2022 6.12 Mn
Jun 30, 2022 11.85 Mn
Mar 31, 2022 7.46 Mn
Dec 31, 2021 6.10 Mn
Sep 30, 2021 7.79 Mn